A new study finds that lower doses of the drug primaquine are as effective at preventing transmission of malaria as standard doses.
Primaquine targets the transmission stages of the malaria parasite, the gametocytes, and is considered an important tool for malaria elimination.
The new study, led by researchers from the London School of Hygiene & Tropical Medicine (LSHTM) in the UK, is published in the latest online issue of The Lancet Infectious Diseases.
The findings are good news because there are not many drugs that target this stage of the disease, and unfortunately, at standard doses primaquine can reduce blood count in people with a red blood cell disorder caused by a deficiency in an enzyme called G6PD.
No comments:
Post a Comment